By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Abbott said this week that its Abbott Molecular business has received the CE Mark for its first DNA sequencing assay developed and introduced by the firm. The Abbott HBV Sequencing test has been developed to identify genomic sequences of the hepatitis B virus. Abbott said that the test is not intended for screening blood donors, plasma, or tissue donors for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.